FTC Saying PBMs Got Some Splainin’ to Do
The outcome of the FTC review of PBM practices and its report on needed corrections may be some of the biggest news items this year. As
August 10, 2023
The outcome of the FTC review of PBM practices and its report on needed corrections may be some of the biggest news items this year. As
The FDA recently approved a new therapy, Rystiggo (rozanolixizumab-Noli) from UCB, for the Treatment of adults with Generalized Myasthenia Gravis (gMG) in adult patients who are
The year was 2019…… and that BUZZ you were hearing was all about drone deliveries of everything from pizza to prescriptions. But by 2020…. mostly crickets! After that warm
If you haven’t added the term ‘blockchain’ to your vocabulary, then it is high time that you do…. starting right now. Blockchain is a system of
The FDA recently approved a new therapy, Litfulo (ritlecitinib) from Pfizer, Inc., a once-daily oral treatment, for individuals 12 years of age and older with
Every day we scan hundreds of articles and press releases to find items, events, trends, developments and other flotsam and jetsam related to specialty pharmacy,
Are you familiar with the Preserving Patient Access to Home Infusion Act (PPAHIA)? You probably should be. It has been kicking around the halls of
FDA has now approved four gene therapies within the past ninety days. That’s got to be a record! The FDA recently approved a new infused
Not all specialty pharmacies operate a compounding line of business….. but there are a number of SPs that do. If your pharmacy is into compounding, then you
Another sonic boom could be heard (well….. at least by dogs) recently when the FDA approved yet another gene therapy! This time the news was truly
